Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation

American Journal of Critical Care

Volumn 7, Issue 5, 1998, Pages 364-369

  Franck, Linda S ^a   Vilardi, Julie ^b   Durand, David ^c   Powers, Richard ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Alta Bates Medical Center   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MORPHINE; NARCOTIC ANALGESIC AGENT;

ARTICLE; COMPARATIVE STUDY; EXTRACORPOREAL OXYGENATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL RECORD; NEWBORN; NURSING; NURSING ASSESSMENT; PATIENT CARE PLANNING; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; EXTRACORPOREAL MEMBRANE OXYGENATION; FENTANYL; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MORPHINE; NURSING ASSESSMENT; NURSING RECORDS; PATIENT CARE PLANNING; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032162146     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc1998.7.5.364     Document Type: Article

References (27)

1. Hickey PR, Hansen DD, Wessel DL, et al. Pulmonary and systemic hemodynamic responses to fentanyl. Anesth Analg. 1985;64:483-486.
2. Irazuzta J, Pascucci R, Perlman N, et al. Effects of fentanyl administration on respiratory system compliance in infants. Crit Care Med. 1993;21:1001-1004.
3. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989;84:957-963.
4. Vaster M, Maxwell LG. Opioid agonists and antagonists. In: Schecter N, Berde CB, Vaster M, eds. Pain in Infants, Children, and Adolescents. Baltimore, Md: Williams & Wilkins; 1993:147.
5. Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr. 1991;119:639-643.
6. Arnold JH, Truog RD, Orav J, et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology. 1990;73:1136-1140.
7. Maguire DP, Maloney P. A comparison of fentanyl and morphine use in neonates. Neonatal Netw. 1988;7:27-32.
8. Caron E, Maguire DP. Current management of pain, sedation and narcotic physical dependency of the infant on ECMO. J Perinat Neonatal Nurs. 1990;4:63-74.
9. Norton SJ. Aftereffects of morphine and fentanyl analgesia: a retrospective study. Neonatal Netw. 1988;7:25-28.
10. Carr DB, Todres ID. Fentanyl infusion and weaning in the pediatric intensive care unit: toward science-based practice. Crit Care Med. 1994;22:725-727.
11. French JP, Nocera M. Drug withdrawal symptoms in children after continuous infusion of fentanyl. J Pediatr Nurs. 1994;9:107-113.
12. Katz R, Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal symptoms in critically ill children who receive fentanyl by continuous infusion. Crit Care Med. 1994;22:763-767.
13. Anand KJS, Arnold JH. Opioid tolerance and dependence in infants and children. Crit Care Med. 1994;22:334-342.
14. Committee on Drugs, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 1983;72:895-1002.
15. Lane JC, Tennison MB, Lawless ST, et al. Movement disorder after withdrawal of fentanyl infusion. J Pediatr. 1991;119:649-651.
16. Bergman I, Steves M, Burckart G, et al. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr. 1991;119:644-648.
17. Franck LS, Vilardi J. Assessment and management of opioid withdrawal in ill neonates. Neonatal Netw. 1995;14:39-48.
18. Seltin DJ, Lawlor-Klean P, Racoma PG. Administration of continuous morphine infusion for the neonate. Neonatal Netw. 1989;8:60-62.
19. Koren G, Butt W, Chinyanga H, et al. Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. J Pediatr. 1985;107:963-967.
20. Finnegan LP, Connaughton JF, Kron RE, et al. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2:141-158.
21. Twycross RG. Opioids. In: Wall PD, Melzack R, eds. Textbook of Pain. New York, NY: Churchill Livingstone; 1994:943-962.
22. Rosen D, Rosen K, Silvasi D, et al. Uptake of narcotics during ECMO: does it really matter which one we choose? Paper presented at: Sixth Annual Children's Hospital National Medical Center ECMO Symposium; February 1990; Washington, DC.
23. Hovav E, Weinstock M. Temporal factors influencing the development of acute tolerance to opiates. J Pharmacol Exp Ther. 1987;242:251-256.
24. McClain DA, Hug CC. Intravenous fentanyl kinetics. Clin Pharmacol Ther. 1980;28:106-114.
25. Benedetti C. Acute pain: a review of its effects and therapy with systemic opioids. In: Benedetti C, Chapman R, Giron G, eds. Advances in Pain Research and Therapy. Vol. 14. New York, NY: Raven Press; 1990:367-424.
26. Jaffe JH. Drug addiction and drug abuse. In: Gilman AG, Wall TW, Nies AS, et al, eds. Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990:522-573.
27. Dagan O, Klein J, Bohn D, et al. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med. 1994;22:1099-1101.